Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T00:43:16.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision indicator advances from v3.7.0 to v3.7.1 while the page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-12T00:28:06.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details content with a standard error screen. This indicates access to the NCT02882282 study record is blocked at the moment.
    Difference
    19%
    Check dated 2026-09-20T23:00:18.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.6.5 to v3.6.6. No study content or data were changed.
    Difference
    0.1%
    Check dated 2026-08-30T21:42:15.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating an internal update to the document version rather than a modification to the study information shown to users.
    Difference
    0.1%
    Check dated 2026-08-09T08:41:25.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing v3.6.3, signaling that a newer version of the study document is referenced on the page.
    Difference
    0.1%
    Check dated 2026-07-25T18:02:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.